Ef. Morand et al., DETECTION OF INTRACELLULAR LIPOCORTIN-1 IN HUMAN-LEUKOCYTE SUBSETS, Clinical immunology and immunopathology, 76(2), 1995, pp. 195-202
Lipocortin 1, a putative mediator of the antiinflammatory actions of g
lucocorticoids, is present intracellularly in a variety of tissues inc
luding human peripheral blood leukocytes. We investigated the presence
of lipocortin 1 in human leukocyte subsets using permeabilization flo
w cytometry. Constitutive lipocortin 1 was detected in U937 myelomonoc
ytic leukemia cells, and lipocortin 1 was increased by treatment with
PMA or PMA + IFN-gamma (P < 0.05) but not by dexamethasone. Lipocortin
1 was present in all leukocyte subsets except B lymphocytes (CD19/20(
+), P < 0.001). Lipocortin 1 content was maximal in monocytes and poly
morphonuclear neutrophils and least in lymphocytes (P < 0.001). Monocy
te lipocortin 1 was strongly associated with surface expression of CD1
4 and HLA-DR. Among non-B lymphocytes, a range of lipocortin 1 fluores
cence was observed. Lipocortin 1 fluorescence was greatest in natural
killer cells (CD56+, P < 0.001) and CD57(+) cells, but T cell subset m
arkers did not otherwise discriminate variations in lipocortin 1. Indu
ction of lymphocyte proliferation by PHA, anti-CD3, Con A, superantige
n, and SAC was not associated with significant shifts in lipocortin 1
content. Dexamethasone (10(-10)-10(-6) M) did not induce increases in
PB leukocyte lipocortin 1. We conclude that lipocortin 1 content in hu
man leukocytes varies significantly among phenotypic subsets. This has
significance for the investigation of inflammatory disease where cert
ain cell types predominate. (C) 1995 academic Press, Inc.